ACGN
Income statement / Annual
Last year (2022), Aceragen, Inc.'s total revenue was $4.86 M,
and the percentage change from the previous year is not available.
In 2022, Aceragen, Inc.'s net income was -$23.36 M.
See Aceragen, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$4.86 M
|
$0.00
|
$0.00
|
$1.45 M
|
$662,000.00
|
$902,000.00
|
$16.20 M
|
$249,000.00
|
$73,000.00
|
$47,000.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$4.86 M |
$0.00 |
$0.00 |
$1.45 M |
$662,000.00 |
$902,000.00 |
$16.20 M |
$249,000.00 |
$73,000.00 |
$47,000.00 |
| Gross Profit Ratio |
1 |
0 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
| Research and Development
Expenses |
$12.19 M
|
$16.38 M
|
$24.77 M
|
$34.85 M
|
$41.84 M
|
$50.65 M
|
$39.82 M
|
$33.70 M
|
$27.49 M
|
$10.48 M
|
| General & Administrative
Expenses |
$12.21 M
|
$9.98 M
|
$11.92 M
|
$12.48 M
|
$15.42 M
|
$16.72 M
|
$15.13 M
|
$15.40 M
|
$11.33 M
|
$7.74 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$12.21 M
|
$9.98 M
|
$11.92 M
|
$12.48 M
|
$15.42 M
|
$16.72 M
|
$15.13 M
|
$15.40 M
|
$11.33 M
|
$7.74 M
|
| Other Expenses |
-$2.40 M |
-$22,000.00 |
$134,000.00 |
$1.11 M |
$1.08 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$24.40 M |
$26.35 M |
$36.69 M |
$47.33 M |
$57.26 M |
$67.37 M |
$54.96 M |
$49.10 M |
$38.83 M |
$18.22 M |
| Cost And Expenses |
$24.40 M |
$26.35 M |
$36.69 M |
$47.33 M |
$57.26 M |
$67.37 M |
$54.96 M |
$49.10 M |
$38.83 M |
$18.22 M |
| Interest Income |
$0.00 |
$9,000.00 |
$165,000.00 |
$1.15 M |
$1.09 M |
$574,000.00 |
$415,000.00 |
$357,000.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$7,000.00 |
$3,000.00 |
$0.00 |
$11,000.00 |
$50,000.00 |
$80,000.00 |
$105,000.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$15,000.00
|
$22,000.00
|
$61,000.00
|
$120,000.00
|
$432,000.00
|
$746,000.00
|
$656,000.00
|
$488,000.00
|
$206,000.00
|
$137,000.00
|
| EBITDA |
-$11.58 M
|
-$150.82 M
|
$39.42 M
|
-$34.14 M
|
-$52.24 M
|
-$65.15 M
|
-$37.69 M
|
-$48.00 M
|
-$38.66 M
|
-$17.98 M
|
| EBITDA Ratio |
-2.38 |
0 |
0 |
-23.58 |
-78.92 |
-72.23 |
-2.33 |
-192.78 |
-529.53 |
-382.45 |
| Operating Income Ratio
|
-5.72
|
0
|
0
|
-31.81
|
-92.08
|
-73.69
|
-2.39
|
-196.17
|
-530.85
|
-386.57
|
| Total Other
Income/Expenses Net |
-$1.86 M
|
$125.76 M
|
-$75.98 M
|
-$10.45 M
|
$1.08 M
|
$483,000.00
|
$368,000.00
|
$291,000.00
|
$110,000.00
|
-$57,000.00
|
| Income Before Tax |
-$29.68 M |
$98.09 M |
-$112.66 M |
-$56.52 M |
-$59.88 M |
-$65.98 M |
-$38.39 M |
-$48.56 M |
-$38.64 M |
-$18.23 M |
| Income Before Tax Ratio
|
-6.1
|
0
|
0
|
-39.03
|
-90.45
|
-73.15
|
-2.37
|
-195
|
-529.34
|
-387.79
|
| Income Tax Expense |
-$6.32 M |
-$124.49 M |
$76.05 M |
$11.62 M |
$3.93 M |
$50,000.00 |
$80,000.00 |
$105,000.00 |
-$110,000.00 |
$57,000.00 |
| Net Income |
-$23.36 M |
$98.09 M |
-$112.66 M |
-$56.52 M |
-$59.88 M |
-$65.98 M |
-$38.39 M |
-$48.56 M |
-$38.64 M |
-$18.23 M |
| Net Income Ratio |
-4.8 |
0 |
0 |
-39.03 |
-90.45 |
-73.15 |
-2.37 |
-195 |
-529.34 |
-387.79 |
| EPS |
-7.17 |
33.48 |
-56.63 |
-33.66 |
-38.27 |
-57.01 |
-40.92 |
-57.38 |
-63.45 |
-56.46 |
| EPS Diluted |
-7.17 |
-9.78 |
-56.63 |
-33.66 |
-38.27 |
-57.01 |
-40.92 |
-57.38 |
-63.45 |
-56.46 |
| Weighted Average Shares
Out |
$3.26 M
|
$2.90 M
|
$1.99 M
|
$1.68 M
|
$1.56 M
|
$1.16 M
|
$938,235.00
|
$846,264.00
|
$609,022.00
|
$322,838.00
|
| Weighted Average Shares
Out Diluted |
$3.26 M
|
$2.95 M
|
$1.99 M
|
$1.68 M
|
$1.56 M
|
$1.16 M
|
$938,235.00
|
$846,264.00
|
$609,022.00
|
$322,838.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
